This pilot clinical trial studies how Brussel sprout consumption affects deuterated phenanthrene metabolism in current and former smokers. Cigarette smoke contains many chemicals called carcinogens which are known to cause cancer. Deuterated phenanthrene is a chemical that does not cause cancer but is processed by the body in the same way as some carcinogens in cigarette smoke or pollution. Brussel sprouts contain a chemical called glucobrassicin that may prevent cancer. Giving participants deuterated phenanthrene and raw Brussel sprouts and studying urine samples in a laboratory may help doctors understand how Brussel sprouts affect the breakdown of deuterated phenanthrene and help doctors figure out which smokers may be at risk for lung cancer.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT02999399.
PRIMARY OBJECTIVE:
I. Determine the effect of a 7-day course of Brussels sprout consumption on deuterated phenanthrene tetraol ([D10]PheT).
SECONDARY OBJECTIVES:
I. Determine the effect of a 7-day course of Brussels sprout consumption on deuterated phenanthrols ([D10]HOP).
II. Determine the effect of a 7-day course of Brussels sprout consumption on the [D10]PheT:[D10]HOP ratio.
EXPLORATORY OBJECTIVES:
I. Determine the correlation between 24 hour (h) urinary 3,3´-diindolymethane (DIM) within an individual with the reduction in [D10]PheT.
II. Determine effect of Brussels sprout consumption on circulating immune cell composition and activity.
OUTLINE:
Participants receive deuterated phenanthrene orally (PO) at baseline and on day 7. Patients also consume raw Brussel sprouts once daily (QD) on days 1-7.
Trial PhaseNo phase specified
Trial Typebasic science
Lead OrganizationUniversity of Minnesota/Masonic Cancer Center
Principal InvestigatorNaomi Fujioka